Shinhan Bank Signs Business Agreement with Korean Pharmaceutical Association...Specialized Loans for Members Affected by COVID-19
[Asia Economy Reporter Kim Hyo-jin] Shinhan Bank announced on the 24th that it signed a business agreement with the Korea Pharmaceutical Association on the 23rd to provide financial support for association members.
Through this agreement, Shinhan Bank will offer preferential interest rates on specialized loan products to 40,000 members of the Korea Pharmaceutical Association who are experiencing business difficulties due to the prolonged COVID-19 pandemic, and provide consulting support programs including financial planning seminars.
In addition, the bank will support the financial operations of association members by offering practical financial benefits such as waiving electronic financial transfer fees, including ATM withdrawal fees.
Hot Picks Today
Taking Annual Leave and Adding "Strike" to Profiles, "It Feels Like Samsung Has Collapsed"... Unsettled Internal Atmosphere
- There Is a Distinct Age When Physical Abilities Decline Rapidly... From What Age Do Strength and Endurance Drop?
- "One Comment Could Lead to a Report": 86% of Elementary Teachers Feel Anxious; Half Consider Resignation or Career Change
- "After Vowing to Become No. 1 Globally, Sudden Policy Brake Puts Companies’ Massive Investments at Risk"
- On Teacher's Day, a Student's Gifted Cake Had to Be Cut into 32 Pieces... Why?
Shinhan Bank plans to enhance user convenience by verifying the membership of the association through open API (Application Programming Interface) and conducting specialized loan products non-face-to-face via a dedicated digital branch, the mobile branch.
At the business agreement ceremony held on the 23rd at the Korea Pharmaceutical Association headquarters in Seocho-gu, Seoul, Park Woo-hyuk, Vice President of Shinhan Bank (right), and Kim Dae-eop, President of the Korea Pharmaceutical Association, are taking a commemorative photo.
View original image© The Asia Business Daily(www.asiae.co.kr). All rights reserved.